Topic: AS02-Epidemiology: COMPARISON OF CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED MDS (T-MDS) AND 4738 PATIENTS FROM THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM DATABASE WITH PRIMARY-MDS (P-MDS). (September 2021) - Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Malcovati, L.; Dezern, A.; Roboz, G.; Steensma, D.; et al.